Global Single-use Airway Diagnostic Devices Market Size By Type (Single-use Accessories, Single-use Endoscopy Devices), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2...

The Global Single-use Airway Diagnostic Devices Market was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.4 billion by 2031, growing at a CAGR of 9.0% during the forecast period from 2023 to 2031. This growth is driven by increasing demand for sterile, disposable diagnostic tools in airway management, rising incidence of respiratory diseases, and stringent regulatory requirements for infection control in medical facilities. Single-use airway diagnostic devices, such as laryngoscopes, bronchoscopes, and endotracheal tube introducers, are widely used in hospitals, ambulatory care centers, and emergency services due to their safety, convenience, and ability to reduce cross-contamination risks.

Drivers

1. Rising Demand for Infection Control:

Single-use devices significantly reduce the risk of cross-contamination and hospital-acquired infections, which has become a major healthcare concern post-COVID-19. This factor is compelling hospitals and clinics to shift towards disposable solutions.

2. Technological Innovations in Disposable Medical Devices:

Advancements such as improved optical visualization, lightweight materials, and ergonomic designs in single-use bronchoscopes and laryngoscopes are enhancing diagnostic accuracy and clinician ease-of-use.

3. Growing Prevalence of Respiratory Disorders:

Increasing global incidence of chronic obstructive pulmonary disease (COPD), asthma, and lung cancer is elevating the demand for efficient, rapid, and sterile diagnostic airway devices.

Restraints

1. Cost Constraints in Low- and Middle-Income Countries:

Despite the clinical benefits, the recurring cost of single-use devices compared to reusable ones poses financial challenges in cost-sensitive healthcare markets.

2. Environmental Concerns:

Rising awareness about medical waste and its environmental impact is creating pressure on manufacturers to innovate with biodegradable or recyclable materials.

Opportunity

1. Expansion of Outpatient and Ambulatory Care Services:

As healthcare systems shift towards outpatient care to reduce costs and improve convenience, the demand for portable and disposable airway diagnostic tools is rising in ambulatory surgical centers and emergency services.

2. Growth in Emerging Markets:

Rapid urbanization, healthcare infrastructure development, and increasing healthcare expenditure in countries like India, Brazil, and China are opening new growth avenues for manufacturers.

Market by System Type Insights

Based on system type, the Single-use Bronchoscopes segment accounted for the largest market share in 2023. Their flexibility, infection control benefits, and ability to deliver real-time diagnostic images make them indispensable in ICU and ER settings. The segment is expected to witness robust growth with rising ICU admissions globally.

Market by End-use Insights

In terms of end-use, Hospitals emerged as the largest segment in 2023, holding over 55% of the market share. Hospitals frequently use these devices for emergency airway management and routine procedures. The Ambulatory Surgical Centers (ASCs) segment is projected to grow at the fastest CAGR during the forecast period due to the rising trend of minimally invasive outpatient procedures.

Market by Regional Insights

North America led the market in 2023, driven by advanced healthcare infrastructure, higher adoption rates of disposable medical devices, and strict infection control protocols. However, Asia-Pacific is projected to be the fastest-growing region through 2031, supported by expanding healthcare access, rising patient awareness, and government investments in medical technology upgrades.

Competitive Scenario

Key players in the market include Ambu A/S, Verathon Inc., Olympus Corporation, Karl Storz SE & Co. KG, Medtronic plc, Boston Scientific Corporation, Teleflex Incorporated, Vyaire Medical, Pentax Medical, and Smiths Medical. Companies are increasingly investing in R&D and strategic collaborations to expand their single-use product lines and strengthen market presence.

Scope of Work – Global Single-use Airway Diagnostic Devices Market

Report Metric Details

Market Size (2023) USD 1.2 Billion

Projected Market Size (2031) USD 2.4 Billion

CAGR (2023-2031) 9.0%

Market Segments By System Type (Bronchoscopes, Laryngoscopes, Others); By End-use (Hospitals, ASCs, Clinics); By Region

Growth Drivers Infection control needs, respiratory disease burden, tech innovations

Opportunities Emerging markets, rise of ASCs, eco-friendly product development

Key Market Developments

2023: Ambu A/S launched a next-generation single-use bronchoscope with enhanced navigation capabilities tailored for ICU and emergency settings.

2024: Verathon announced a strategic partnership with a major U.S. hospital chain to supply disposable laryngoscopes for all emergency and trauma departments.

2025: Olympus Corporation introduced a sustainable single-use airway diagnostics line utilizing biodegradable plastics, addressing environmental concerns.

FAQs

1) What is the current market size of the Global Single-use Airway Diagnostic Devices Market?

The market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global Single-use Airway Diagnostic Devices Market?

Infection control and the rising burden of respiratory diseases are the primary growth drivers.

3) Which is the largest region during the forecast period in the Global Single-use Airway Diagnostic Devices Market?

North America is the largest region, while Asia-Pacific is expected to grow fastest.

4) Which segment accounted for the largest market share in the Global Single-use Airway Diagnostic Devices Market?

The Single-use Bronchoscopes segment led the market by system type in 2023.

5) Who are the key market players in the Global Single-use Airway Diagnostic Devices Market?

Key players include Ambu A/S, Verathon Inc., Olympus Corporation, Karl Storz, and Medtronic.